Advertisement

Pain Management

Home Pain Management
More than 50 million Americans live with a physical or mental disability

CDC: 20 Percent of U.S. Adults Have a Disability

Race, poverty, and less education linked to increased odds of having a disability
For obese individuals

Home-Based Device Beneficial for Obese Patients With Knee OA

Biomechanical device tied to improvement in all gait parameters at three, 12 months
Led by the American Medical Association

U.S. Medical Groups Fighting Prescription Opioid Abuse

Special Task Force aims to curb 'epidemic' of addiction to opioids such as Oxycontin, Vicodin
Vertebral osteomyelitis should be considered in cases of back or neck pain unresponsive to conservative measures and elevated inflammatory markers with or without fever

Recalcitrant Back Pain Could Be Vertebral Osteomyelitis

New guidelines from ISDA alert doctors to this possibility
The 2015 version of the American Board of Internal Medicine maintenance-of-certification program is expected to generate considerable costs

2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years

Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
For patients with neural foraminal or lateral recess stenosis with unilateral leg neurogenic symptoms

No Lasting Value for Minimally Invasive Lumbar Laminotomy

No differences or improvement in back or leg pain, ODI, neurogenic symptoms, SF-36 scores
Millions more Americans have affordable health insurance

Patients Report Improved Care Access, Better Health With ACA

Gains seen in how many adults have insurance and a doctor, and say they are in better health
Not all placebos are equally effective for knee osteoarthritis and some can trigger clinically relevant responses

Not All Placebos Are Equal in Knee Osteoarthritis

Differential placebo effects can alter estimates of the relative efficacies of active treatments
For older adults presenting to their primary care providers with a new visit for back pain

Earlier Physical Therapy May Help Older Patients With Back Pain

Extent of improvement in symptoms may be greater among those referred for early PT
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

Analysis found roughly 10 percent of cases were filed after 15-day deadline passed